Manufactured by:ProteoGenix
Save 20%RUO

Recombinant Human VPS8 Protein, N-His

Recombinant Human VPS8 Protein, N-His from ProteoGenix; catalogue ARO-P10728; research use only.

SKU:
ABM141167-1
Manufacturer SKU
ARO-P10728
Product type
Recombinant Proteins
Expression systemProkaryotic expression

Manufacturer provenance

Manufactured by:
ProteoGenix
Sold by:
ABMIUM
Fulfilled from:
Manufacturer facility or confirmed fulfilment location

Know who made it. See the evidence. Buy through one marketplace.

Product description

Introduction

Recombinant Human VPS8 Protein, also known as Vacuolar Protein Sorting 8 Homolog (VPS8), is a protein that plays a crucial role in intracellular protein trafficking and sorting. It is a member of the VPS8 family, which is involved in the formation and maturation of endosomes, lysosomes, and autophagosomes. Recombinant VPS8 Protein is produced through genetic engineering techniques, making it a highly pure and specific protein with a wide range of applications in various fields of research and medicine.

Structure of Recombinant Human VPS8 Protein

Recombinant Human VPS8 Protein is a 102 kDa protein consisting of 925 amino acids. It contains a conserved VPS8 domain, which is responsible for its function in intracellular trafficking. The protein also has several other domains, including a coiled-coil domain, a WD40 repeat domain, and a C2 domain. These domains are essential for protein-protein interactions and membrane binding, allowing VPS8 to perform its cellular functions.

Activity of Recombinant Human VPS8 Protein

Recombinant Human VPS8 Protein is involved in the process of endosomal sorting and trafficking. It functions as a subunit of the Class C VPS complex, which is responsible for the fusion of endosomes with lysosomes and the formation of multivesicular bodies. VPS8 interacts with other subunits of the VPS complex, such as VPS11 and VPS18, to regulate the formation and maturation of endosomes and lysosomes. It also plays a role in autophagosome formation, a process that involves the degradation of cellular components through the lysosomal pathway.

Application of Recombinant Human VPS8 Protein

Recombinant Human VPS8 Protein has a wide range of applications in both research and medicine. Its role in intracellular trafficking makes it a valuable tool for studying the mechanisms of endosome and lysosome formation. It can also be used to investigate the molecular basis of diseases related to defects in these processes, such as lysosomal storage disorders and neurodegenerative diseases.

Furthermore, Recombinant Human VPS8 Protein has potential therapeutic applications. It has been identified as a potential target for cancer therapy, as it is involved in the regulation of cell growth and proliferation. Studies have shown that inhibiting VPS8 activity can lead to the death of cancer cells, making it a promising target for the development of anti-cancer drugs.

In addition, Recombinant Human VPS8 Protein has been shown to play a role in the immune response. It is a key player in the antigen processing and presentation pathway, where it helps to deliver antigens to MHC class II molecules for presentation to T cells. This makes it a potential target for the development of vaccines and immunotherapies.

Conclusion

Recombinant Human VPS8 Protein is a crucial protein involved in intracellular trafficking and sorting. Its structure and activity have been extensively studied, and it has been identified as a potential therapeutic target for various diseases. Its wide range of applications in research and medicine make it a valuable tool for understanding cellular processes and developing new treatments. With further research, Recombinant Human VPS8 Protein has the potential to make significant contributions to the fields of biology, medicine, and biotechnology.

ProteoGenix catalogue number ARO-P10728. For research use only.

Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 19.79 kDa; Fragment: Val819-Glu966; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..

Available configurations: 50ug, 100ug, 1mg.

Download the manufacturer datasheet

Key facts & specifications
Also known as
VPS8, KIAA0804, Vacuolar protein sorting-associated protein 8 homolog
Host species
E. coli
Source organism
Human
Molecular weight
19.79 kDa
Sequence fragment
Val819-Glu966
Sequence
VMVENSDFTPSQVGCLFTFLARQLAKPDNTLFVNRTLFDQVLEFLCSPDDDSRHSERQQVLLELLQAGGIVQFEESRLIRMAEKAEFYQICEFMYEREHQYDKIIDCYLRDPLREEEVFNYIHNILSIPGHSAEEKQSVWQKAMDHIE
Technical note
For research use only.
Identifiers & database references
Manufacturer SKU
ARO-P10728
UniProt accession
Q8N3P4
Storage, stability & shipping
Storage conditions
4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
Shipped at
Dry Ice
Compliance & documents
ISO certifications
ISO 9001:2023, ISO 14001: 2023
Datasheet
Open datasheet
Frequently asked questions
Who manufactured this product?

This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.

Can ABMIUM ship this product internationally?

ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.

Can I check suitability before ordering?

Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.

Is this product for clinical use?

Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.

ProteoGenix
$239.00$192.00